This intra-tumor heterogeneity was more evident for some markers such as the cell adhesion molecule CD34 and the α3 and β1 integrins (CD49c and CD61 respectively) which were expressed only by highly restricted subpopulations of some PDHGG patient-derived cell lines. This evidence concerns the gene CD34 and neoplasm.